NVCR

Novocure Stock Analysis

AI Rating

Fair
  • Quality1/10
  • Growth↑ 5/10
  • Value↓ 1/10
Novocure sales and earnings growth
NVCR Growth
Neutral
  • Revenue Y/Y↑ 8.48%
  • EPS Y/Y↓ -1.32%
  • FCF Y/Y↑ 33.36%
Novocure gross and profit margin trends
NVCR Profitability
Fair
  • Gross margin ↑ 75.20%
  • EPS margin↓ -25.70%
  • ROIC 5Y↓ -15.68%
Novocure net debt vs free cash flow
NVCR Risk
Great
  • Debt / Equity↓ 0.7
  • Debt / FCF↓ 2.9
  • Interest coverage↓ -22.5

Novocure stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Medical Devices stocks